Clinical Research Directory

Inclusion Criteria: * Pregnancy of \< or = 77 days duration based on LMP or ultrasound * Positive pregnancy test (self-report or in-clinic) * Age: States without parental involvement laws : in-person patients ages 14 years and older; States with parental involvement or notification laws: 18 years or older * Willing and able to give informed consent * Willing to comply with study protocol * Willing to record requested information in the study surveys * English or Spanish speaking * Has a text message, email, or phone call capable device for survey completion * Understands and signs an Institutional Review Board (IRB) approved informed consent form prior to undergoing any study procedures or randomization Exclusion Criteria: * concurrent participation in any other interventional trial * unwilling to comply with the study protocol and survey/visit schedule * contraindication to mifepristone (chronic corticosteroid administration, adrenal disease) * contraindication to misoprostol (glaucoma, mitral stenosis, sickle cell anemia, or known allergy to prostaglandin) * cardiovascular disease (angina, valvular disease, arrhythmia, or cardiac failure) * diagnosis of porphyria * known bleeding disorder or receiving anticoagulants * pregnancy with an IUD in place * diagnosis of pregnancy of unknown location (PUL), early pregnancy failure, incomplete or inevitable abortion (absent gestational sac and/or open cervical os) * possibility of ectopic pregnancy * known or suspected pelvic infection * Have issues or concerns (in the judgement of the investigator) that may compromise the safety of the subject or confound the reliability of compliance and information acquired in this study. * Have previously participated in the study * Be a site staff member with delegated study responsibilities or a family member of, or have a close relationship with, a site staff member with delegated study responsibilities.